InsiderTrades

Form 4 for MRNA Moderna

Accepted 2025-12-01 00:00:00 ET · period of report 2025-11-26 · accession 0001682852-25-000078 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2025-12-01 2025-11-26+ MRNA Hoge Stephen Pres F - Tax $24.83 -990 1.45M -0.1% -$24.6K
DM 2025-12-01 2025-11-26+ MRNA Hoge Stephen Pres M - OptEx — +2,047 1.45M +0.1% —
DM 2025-12-01 2025-11-26+ MRNA Hoge Stephen Pres M - OptEx $0.00 -2,047 12.9K -14% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-11-26 F D 695 $24.75 1,454,254 D — —
2 Common Common Stock 2025-11-28 F D 295 $25.01 1,454,569 D — —
3 Common Common Stock 2025-11-28 M A 610 — 1,454,864 D — — (F1) Restricted stock units convert into common stock on a one-for-one basis.
4 Common Common Stock 2025-11-26 M A 1,437 — 1,454,949 D — — (F1) Restricted stock units convert into common stock on a one-for-one basis.
5 Derivative Restricted Stock Units 2025-11-28 M D 610 $0.00 3,053 D — · — to — 610 Common Stock (F1) Restricted stock units convert into common stock on a one-for-one basis. (F5) 25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
6 Derivative Restricted Stock Units 2025-11-26 M D 1,437 $0.00 12,931 D — · — to — 1,437 Common Stock (F1) Restricted stock units convert into common stock on a one-for-one basis. (F4) 25% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter.